At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. BURLINGAME, CA, UNITED STATES, March 12, 2025 /EINPresswire ...

Aspen Pharmacare’s shares plunged as much as 33% (losing over R53 a share) on Wednesday afternoon, but later recovered ...

and KNOXVILLE, Tenn. – The Chao Center for Industrial Pharmacy and Contract Manufacturing will increase its pharmaceutical development and production to include other drugs for niche markets in ...

said Thursday it has signed an initial pact with U.S. biotech firm Asimov Inc. for partnership in contract pharmaceutical manufacturing. The agreement will allow Lotte Biologics to use Asimov's ...

West Pharmaceutical Services WST is scheduled to release first-quarter 2025 results on April 24, before the opening bell. In ...

The Orphan Therapeutics Accelerator (OTXL), a non-profit biotech organization focused on completing development and ...

Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing contract ... of both the active pharmaceutical ingredient, or ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore”), a fully integrated contract development and manufacturing organization ...

He reaffirmed that Avalon Pharma remains committed to manufacturing pharmaceutical products that meet global ... whether in negligence, tort, contract or any other theory of liability, even if the ...